Key Events This Week
3 Aug: Death Cross formation signals potential bearish trend
4 Aug: Downgrade to Sell amid technical weakness and promoter pledge concerns
7 Aug: Week closes at Rs.102.00, down 2.49%
Aug 12, 03:30 PM
BSE+NSE Vol: 11.3 k

Lactose (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators, valuation metrics, financial trends, and overall quality assessment. This upgrade comes amid strong quarterly financial performance and a shift in market sentiment, positioning the micro-cap pharmaceutical company for cautious optimism among investors.
Read full news article
3 Aug: Death Cross formation signals potential bearish trend
4 Aug: Downgrade to Sell amid technical weakness and promoter pledge concerns
7 Aug: Week closes at Rs.102.00, down 2.49%
The next results date for Lactose (India) Ltd is scheduled for 11 August 2026....
Read full news article
Lactose (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 3 August 2026. This shift is primarily driven by a deterioration in technical indicators, despite the company’s robust financial performance and attractive valuation metrics. Investors are advised to weigh the mixed signals from quality, valuation, financial trends, and technicals before making decisions.
Read full news article
Lactose (India) Ltd has recently formed a Death Cross, a significant technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, reflecting a deterioration in the stock’s medium to long-term momentum and raising concerns about sustained weakness in the Pharmaceuticals & Biotechnology sector micro-cap.
Read full news article
Lactose (India) Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators alongside robust financial performance in the latest quarter. The company’s valuation remains attractive amid healthy long-term growth, while certain risks persist due to promoter share pledging. This comprehensive analysis explores the four key parameters that influenced the rating change: Quality, Valuation, Financial Trend, and Technicals.
Read full news article
Lactose (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 20 Jul 2026. This decision follows a comprehensive reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals. Despite robust long-term growth and improving profitability, the downgrade reflects emerging concerns over technical indicators and promoter share pledging, which could weigh on near-term price performance.
Read full news article
Lactose (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 June 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 14 July 2026, providing investors with the latest comprehensive view of the company’s performance and outlook.
Read full news article
Lactose (India) Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 July 2026, providing investors with the latest insights into its performance and outlook.
Read full news articleIn compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform to the Exchange that the Board of Directors of the Company at their meeting held on Tuesday 11th August 2026. The Meeting of the Board of Directors of the Company was commenced at 12.00 Noon and concluded at 02.30 P.M.
We are submitting the Un audited Financial Result along with Auditor report of the Company for first quarter ended as on 30th June 2026
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. To consider and approve Un-Audited Financial Results of the Company along with the Limited Review Report issued by statutory auditor of the company for the First quarter ended 30th June 2026; 2. To consider any other business with the permission of chair
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available